Table 2.
Analyses of HMA combinations with Doxo on BCP-ALL cells
| Drug combination effect | |||||||
|---|---|---|---|---|---|---|---|
| AZA + Doxo | AZA + Doxo (24 h) | Doxo + AZA (24 h) | DEC + Doxo | DEC + Doxo (24 h) | Doxo + DEC (24 h) | ||
| SEM | Metabolism | − 0.071 | − 0.230 | 0.006 | − 0.046 | − 0.117 | − 0.021 |
| Proliferation | − 0.002 | − 0.192 | 0.015 | − 0.014 | − 0.094 | − 0.042 | |
| RS4;11 | Metabolism | − 0.009 | − 0.118 | 0.086 | − 0.007 | − 0.071 | 0.044 |
| Proliferation | − 0.022 | − 0.227 | 0.016 | − 0.028 | − 0.301 | 0.011 | |
Drug combination effect: difference between the observed and the expected inhibition (E) of combined treatment. E is calculated as follows: E = (A + B) − (A*B); A is inhibition effect of drug A; B inhibition effect of drug B values > 0: synergistic, values < 0: antagonistic